0001493152-23-033251.txt : 20230921 0001493152-23-033251.hdr.sgml : 20230921 20230920193054 ACCESSION NUMBER: 0001493152-23-033251 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230919 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHINECO, INC. CENTRAL INDEX KEY: 0001300734 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 522175898 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37776 FILM NUMBER: 231267537 BUSINESS ADDRESS: STREET 1: T1, SOUTH TOWER STREET 2: JIAZHAOYE SQUARE CITY: CHAOYANG DISTRICT, BEIJING, STATE: F4 ZIP: 100022 BUSINESS PHONE: (86) 10-68329620 MAIL ADDRESS: STREET 1: T1, SOUTH TOWER STREET 2: JIAZHAOYE SQUARE CITY: CHAOYANG DISTRICT, BEIJING, STATE: F4 ZIP: 100022 FORMER COMPANY: FORMER CONFORMED NAME: SUPCOR, INC. DATE OF NAME CHANGE: 20050328 FORMER COMPANY: FORMER CONFORMED NAME: Supcor, Inc. DATE OF NAME CHANGE: 20041015 FORMER COMPANY: FORMER CONFORMED NAME: SupCor, Inc. DATE OF NAME CHANGE: 20040817 8-K 1 form8-k.htm
0001300734 false 0001300734 2023-09-19 2023-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) September 19, 2023

 

SHINECO, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37776   52-2175898

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

T1, South Tower, Jiazhaoye Square

Chaoyang District,

Beijing, People’s Republic of China

   100062
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (+86) 10-67084339

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   SISI   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 2.01 Completion of Acquisition or Disposition of Assets

 

On September 19, 2023, Shineco Life Science Group Hong Kong Co., Limited (“Shineco Life”), a company established under the laws of Hong Kong and a wholly owned subsidiary of Shineco, Inc. (the “Company” together with Shineco Life as the “Buying Parties”) closed the acquisition of 71.42% equity interest (the “Acquisition”) in Dream Partner Limited, a BVI corporation (“Dream Partner”), pursuant to previously announced stock purchase agreement (the “Agreement”) dated May 29, 2023, entered into by and among the Buying Parties, Dream Partner, Chongqing Wintus Group, a corporation incorporated under the laws of mainland China (“Wintus”) and certain shareholders of Dream Partner (the “Sellers,” together with Dream Partner and Wintus as the “Selling Parties”).

 

As the consideration for the Acquisition, the Company (a) paid the Sellers an aggregate cash consideration of $2,000,000 (the “Cash Consideration”); (b) issued certain shareholders, as listed in the Agreement, an aggregate of 10,000,000 shares of the Company’s restricted Common Stock (the “Shares”); and (c) transferred and sold to the Sellers 100% of the Company’s equity interest in Beijing Tenet-Jove Technological Development Co., Ltd. (the “Tenet-Jove Shares”).

 

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a form of which is filed herein as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on March 23, 2023, the Company received notice from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based on the previous 30 consecutive business days, the Company’s listed security no longer met the minimum $1 bid price per share requirement. In accordance with its Listing Rules, Nasdaq granted the Company 180 calendar days, or until September 18, 2023, to regain compliance. In order to regain compliance, the closing bid price of the Company’s common stock (the “Common Stock”), must have been at least $1 per share for a minimum of ten consecutive business days during this 180-day period. The Company’s Common Stock has not regained compliance with the minimum $1 bid price per share requirement as of that date. By letter dated September 6, 2023, the Company requested an extension of an additional 180 days in which to regain compliance.

 

On September 19, 2023, the Company received notice from Nasdaq indicating that, while the Company has not regained compliance with the minimum bid price requirement, staff of Nasdaq has determined that the Company is eligible for an additional 180-day period, or until March 18, 2024, to regain compliance. Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of our publicly held shares and all other applicable requirements for initial listing on the Capital Market, with the exception of the bid price requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure the deficiency during this second compliance period by effecting a reverse stock split, if necessary.

 

The Company will continue to monitor the closing bid price of its Common Stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted compliance periods. If the Company does not regain compliance by March 18, 2024, Nasdaq will provide written notification that the Company’s securities will be delisted. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.

 

The Company intends to actively monitor the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. However, there can be no assurance that the Company will regain compliance with the Minimum Bid Requirement during the 180-day compliance period or maintain compliance with the other Nasdaq listing requirements.

 

Item 3.02. Unregistered Sales of Equity Securities.

 

The description of the Shares issued to certain shareholders in Item 1.01 of this Report is incorporated by reference into this Item 3.02. The Shares have been issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), which exempts transactions by an issuer not involving any public offering, or pursuant to Regulation S under the Securities Act to non-United States residents who are not a “U.S. person” as defined in Rule 902(k) of Regulation S and are not acquiring the Shares for the account or benefit of any U.S. person.

 

Exhibit Number   Description
     
10.1   Stock Purchase Agreement
104   Cover Page Interactive Data File (embedded within the Inline XBRL document and included as Exhibit 101).

 

   

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 20, 2023 SHINECO, INC.
     
  By: /s/ Jennifer Zhan
  Name:  Jennifer Zhan
  Title: Chief Executive Officer

 

   

 

 EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

STOCK PURCHASE AGREEMENT

between

Wang Xiaohui and Yan Chi Keung

(“Sellers”)

 

Dream Partner Limited

(“Company”)

 

Shineco, Inc.

(“Parent”)

 

Chongqing Wintus Group

(“Wintus”)

and

Shineco Life Science Group Hong Kong Co., Limited

(Buyer)

dated as of

May 29, 2023

 

 

 

 

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement (this “Agreement”), dated as of the date first written above, is entered into between Wang Xiaohui and Yan Chi Keung (individually as the “Seller” and collectively as the “Sellers”), Shineco, Inc., a Delaware Corporation (“Parent”), Shineco Life Science Group Hong Kong Co., Limited, a Hong Kong corporation (“Buyer”), Dream Partner Limited, a BVI corporation (the “Company”) Chongqing Wintus Group, a corporation incorporated under the laws of mainland China (“Wintus”). Capitalized terms used in this Agreement have the meanings given to such terms herein.

 

RECITALS

 

WHEREAS, the Company is a holding company incorporated in British Virgin Islands, and is engaged in the manufacturing silk products through its wholly subsidiary Wintus.

 

WHEREAS, Sellers collectively own 100% equity interests (the “Equity Interests”), of the Company in the amounts set forth on Exhibit A. However, Wang Xiaohui is the record holder of the Equity Interests on behalf of Persons listed in Exhibit D;

 

WHEREAS, the Buyer is a wholly owned subsidiary of the Parent;

 

WHEREAS, Beijing Tenet-Jove Technological Development Co., Ltd. (“Tenet-Jove”) is a wholly-owned subsidiary of the Parent; and

 

WHEREAS, Sellers wish to sell to Buyer, and Buyer wishes to purchase from the Sellers, the Shares (as defined below) for a Purchase Price (as defined below) of $27,500,000, subject to the terms and conditions set forth herein;

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

ARTICLE I

Purchase and sale

 

Section 1.01 Purchase and Sale. Subject to the terms and conditions set forth herein, at the Closing Date (as stated under Closing Confirmation Letter), Sellers shall sell to Buyer, and Buyer shall purchase from Sellers, a total of 71.42% of the Equity Interests in the respective amount as forth in Exhibit B (the “Shares”), free and clear of any mortgage, pledge, lien, charge, security interest, claim, community property interest, option, equitable interest, restriction of any kind (including any restriction on use, voting, transfer, receipt of income, or exercise of any other ownership attribute), or other encumbrance (each, an “Encumbrance”) .

 

Section 1.02 Purchase Price. In payment of the Shares, the Parent shall pay the Sellers (a) an aggregate cash consideration of $2,000,000, in the respective amount as set forth in Exhibit C (the “Cash Consideration”); (b) shall issue an aggregate of 10,000,000 shares of the Parent’s restricted common stock to certain shareholders in the amounts set forth in the Exhibit D, free from any Encumbrance (the “Parent Shares”); and (c) shall transfer and sell to the Sellers its 100% equity interest in Tenet-Jove, in the respective amounts set forth in the Exhibit E, free from any Encumbrance (“the “Tenet-Jove Shares,” together with the Cash Consideration and the Parent Shares as the “Purchase Price”). Buyer shall pay the Cash Consideration to Sellers at the Closing by wire transfer of immediately available funds in accordance with the wire transfer instructions set forth in Section 1.02 of the Disclosure Schedules. The term “Disclosure Schedules” means the disclosure schedules, attached hereto and made a part hereof, delivered by Sellers and Buyer concurrently with the execution, closing, and delivery of this Agreement.

 

2

 

 

ARTICLE II

CLOSING

 

Section 2.01 Closing. The closing of the purchase and sale of the Shares contemplated by this Agreement (the “Closing”) shall take place on a date that is no later than forty five (45) Business Days following the date of the Closing Confirmation Letter. The parties to the agreement shall sign the “Closing Confirmation Letter” as set forth in Annex I, to confirm the Closing Date and the Closing shall be effected remotely by the electronic exchange of documentation and will be effective on the Closing Date. “Business Day” means any day other than a Saturday, Sunday, or public holiday under the laws of the State of New York.

 

Section 2.02 Selling Parties Closing Deliverables. At the Closing, each Seller, the Company and Wintus (individually as the “Selling Party” and collectively the “Selling Parties”), as the case may be, shall deliver to Buying Parties the following:

 

(a) An executed copy of the Agreement.

 

(b) Equity certificates evidencing Sellers ownership of the Shares, free and clear of all Encumbrances, duly endorsed in blank or accompanied by stock powers or other instruments of transfer duly executed in blank.

 

(c) Reserved.

 

(d) A signed power of attorney agreement.

 

(e) Upon execution of this Agreement, a unanimous written consent from the board of directors of the Company approving the transactions set forth herein.

 

(f) A good standing certificate (or its equivalent) for the Company from the secretary of state or similar governmental authority of the jurisdiction in which the Company is organized and each jurisdiction where the Company is required to be qualified, registered, or authorized to do business.

 

(g) Appropriate documentation evidencing the ownership and registration of the Buyer as the beneficial owner of the Shares in the corporate records of the Company, representing 71.42% of the Equity Interest in the Company.

 

(h) A good standing certificate (or its equivalent) for Wintus from the secretary of state or similar governmental authority of the jurisdiction in which Wintus is organized and each jurisdiction where Wintus is required to be qualified, registered, or authorized to do business

 

3

 

 

(i) All other agreements, certifications, and other documents required to be executed and delivered by the Sellers and the Company, as applicable, hereunder at the Closing

 

Section 2.03 Buying Parties Closing Deliveries. At the Closing, Buyer and the Parent (individually as the “Buying Party” and collectively as the “Buying Parties”), as applicable, shall deliver the following to Seller:

 

(a) An executed copy of the Agreement.

 

(b) Upon closing, proof of registration of the Seller as the beneficial owners of the Parent Shares and the Tenet-Jove Shares in the corporate records of the Parent and Tenet-Jove, respectively.

 

(c) The Purchase Price.

 

(d) Reserved.

 

(e) To Sellers, written consent from the board of directors of each Buying Party, as applicable, approving the transaction set forth in this Agreement on the Closing Date.

 

(f) To the Sellers, all other agreements, certifications, and other documents required to be executed and delivered by Buyer, Tenet-Jove or Parent hereunder at the Closing

 

ARTICLE III

Representations and warranties of sellING PARTIES

 

Each of the Selling Parties represents and warrants to Buyer that the statements contained in this ARTICLE III are true and correct as of the date hereof. For purposes of this ARTICLE III, “Sellers’ knowledge,” “knowledge of Sellers,” “Company’s knowledge,” “knowledge of the Company,” “Selling Party’s knowledge,” “Wintus’ knowledge,” “knowledge of Wintus” and any similar phrases shall mean the actual or constructive knowledge of the respective Selling Party, after due inquiry. Authority of Sellers. Sellers are individuals with full civil capacity under the Laws of the state of the People’s Republic of China. Sellers have full power and authority to enter into this Agreement and the other Transaction Documents to which Sellers is a party, to carry out its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby.

 

4

 

 

Section 3.01 This Agreement and any other Transaction Documents constitutes the legal, valid, and binding obligation of the Selling Parties, enforceable against the respective Selling Party in accordance with its terms. There is no pending legal proceeding that has been commenced against either of the Selling Parties and that challenges, or may have the effect of preventing, delaying, making illegal, or otherwise interfering with the performance of this Agreement or the transactions contemplated herein. To the respective Selling Party’s knowledge, no such proceeding has been threatened.

 

Section 3.02 Organization, Authority, and Qualification of the Company and its Subsidiaries. The Company and its subsidiaries, including Wintus, are duly organized, validly existing, and in good standing under the Laws of the respective jurisdictions where the Company and its subsidiaries, including Wintus, were incorporated, and have full corporate power and authority to own, operate, or lease the properties and assets now owned, operated, or leased by it and to carry on its business as it has been and is currently conducted. Section 3.03 of the Disclosure Schedules sets forth each jurisdiction in which the Company and its subsidiaries, including Wintus, are licensed or qualified to do business, and the Company and its subsidiaries, including Wintus, are duly licensed or qualified to do business and is in good standing in each jurisdiction in which the properties owned or leased by them or the operation of their business as currently conducted makes such licensing or qualification necessary.

 

Section 3.03 Ownership. If the Selling Party is an entity, Schedule 3.04 sets forth, as of the date hereof, the respective Selling Party’s direct or indirect ownership interest in any subsidiary companies or any other Person, its percentage ownership interest therein (and the ownership interest of any other Person therein) and the jurisdiction in which each subsidiary was organized. Each of the subsidiaries is a corporation or other entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation. The subsidiaries have all necessary corporate power and authority to own or lease their respective properties and assets, as applicable, and to carry on their respective businesses as now conducted and are duly qualified or licensed to do business as foreign corporations or other entities in good standing in all jurisdictions in which the ownership of their property or the conduct of their business requires such qualification. Schedule 3.04 sets forth the board of directors, if applicable, and executive officers of each subsidiary.

 

Section 3.04 Capitalization of the Company.

 

(a) The Shares are owned of record and beneficially by Sellers, free and clear of all Encumbrances. All necessary steps for the transfer of Shares have been taken and upon the transfer, assignment, and delivery of the equity interest and payment therefor in accordance with the terms of this Agreement, Buyers shall own 71.42% of the Equity Interest in the Company, free and clear of all Encumbrances.

 

(b) All of the equity interest were issued in compliance with applicable Laws. None of the Equity Interest were issued in violation of any agreement or commitment to which Sellers or the Company is a party or is subject to or in violation of any preemptive or similar rights of any individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association, or other entity (each, a “Person”).

 

5

 

 

(c) There are no outstanding or authorized options, warrants, convertible securities, stock appreciation, phantom stock, profit participation, or other rights, agreements, or commitments relating to the shares of the Company or obligating the Company to issue or sell any shares of, or any other interest in, the Company. There are no voting trusts, stockholder agreements, proxies, or other agreements in effect with respect to the voting or transfer of any of the Shares.

 

(d) The Company agrees to not issue equity capital that would have the effect of diluting Buyer’s ownership position in the Company without Buyer’s prior written consent.

 

Section 3.05 Capitalization of Wintus.

 

(a) The 100% equity interest in Wintus is owned of record and beneficially by the Company, free and clear of all Encumbrances.

 

(b) All of the equity interest were issued in compliance with applicable Laws. None of the equity interest were issued in violation of any agreement or commitment to which Wintus or the Company is a party or is subject to or in violation of any preemptive or similar rights of any Person.

 

(c) There are no outstanding or authorized options, warrants, convertible securities, stock appreciation, phantom stock, profit participation, or other rights, agreements, or commitments relating to the shares of Wintus or obligating Wintus to issue or sell any shares of, or any other interest in Wintus. There are no voting trusts, stockholder agreements, proxies, or other agreements in effect with respect to the voting or transfer of any of the outstanding shares in Wintus.

 

(d) Wintus agrees to not issue equity capital that would have the effect of diluting the Company’s ownership position in Wintus without Buyer’s prior written consent.

 

Section 3.06 No Conflicts or Consents. The execution, delivery, and performance, by the Selling Parties, of this Agreement and the other Transaction Documents to which it is a party, and the consummation of the transactions contemplated hereby and thereby, do not and will not: (a) violate or conflict with any provision of the certificate of incorporation, by-laws, or other governing documents of the Company and its subsidiaries; (b) violate or conflict with any provision of any statute, law, ordinance, regulation, rule, code, treaty, or other requirement of any Governmental Authority (collectively, “Law”) or any order, writ, judgment, injunction, decree, determination, penalty, or award entered by or with any Governmental Authority (“Governmental Order”) applicable to Selling Parties; (c) require the consent, notice, or filing with or other action by any Person or require any Permit, license, or Governmental Order; (d) violate or conflict with, result in the acceleration of, or create in any party the right to accelerate, terminate, or modify any contract, lease, deed, mortgage, license, instrument, note, indenture, joint venture, or any other agreement, commitment, or legally binding arrangement, whether written or oral (collectively, “Contracts”), to which the Selling Parties are a party or by which the Selling Parties are bound or to which any of their respective properties and assets are subject; or (e) result in the creation or imposition of any Encumbrance on any properties or assets of the Selling Parties.

 

6

 

 

Section 3.07 Financial Statements. Complete copies of the Company’s consolidated audited financial statements consisting of the balance sheet of the Company for the year ended June 30, 2022 and 2021, and as of the last day of the last quarter (if any) prior to the Closing Date and the related statements of income and retained earnings, stockholders’ equity, and cash flow for the years then ended (the “Financial Statements”) shall be provided to the Buying Parties within 75 days from the Closing Date. The Financial Statements will be prepared in accordance with generally accepted accounting principles in effect in the United States from time to time (“GAAP”), applied on a consistent basis throughout the period involved. The Financial Statements will be based on the books and records of the Company and fairly present the financial condition of the Company as of the respective dates they were prepared and the results of the operations of the Company for the periods indicated. The Company maintains a standard system of accounting established and administered in accordance with GAAP.

 

Section 3.08 Undisclosed Liabilities. Except as set forth on Schedule 3.09, the Selling Parties have no liabilities, obligations, or commitments of any nature whatsoever, whether asserted, known, absolute, accrued, matured, or otherwise (collectively, “Liabilities”), except: (a) those which are adequately disclosed to the Buying Parties; and (b) those which have been incurred in the ordinary course of business consistent with past practice and which are not, individually or in the aggregate, material in amount.

 

Section 3.09 Absence of Certain Changes, Events, and Conditions. Except as set forth on Schedule 3.10, as of the date of this Agreement, the Company and its subsidiaries have been operating in the ordinary course of business consistent with past practice and there has not been:

 

(a) acquisition of any stock or business of, or merger or consolidation with, another Person, or any action with respect to liquidating, dissolving, recapitalizing, reorganizing or otherwise winding up the Company’s or its subsidiaries business;

 

(b) payment or increase by the Company or its subsidiaries of any bonuses, salaries, or other compensation to any stockholder, director, officer, or employee (except, with respect to non-executive employees, in the ordinary course of business consistent with past practice) or entry into any new, or material amendment of any existing, employment, consulting, independent contractor, severance, change of control or similar contract;

 

(c) adoption of any profit sharing, bonus, deferred compensation, savings, insurance, pension, retirement, or other employee benefit plan;

 

(d) damage to or destruction or loss of any asset or property of the Company or its subsidiaries, whether or not covered by insurance, which has had, or would reasonably be expected to have, a Material Adverse Effect on the Company or its subsidiaries;

 

7

 

 

(e) sale (other than sales of Equipment in the ordinary course of business), lease, license, distribution or other disposition of any material asset(s) or property of the Company or its subsidiaries, or any waiver, release, transfer or assignment of any right of material value, or any mortgage, pledge, or imposition of any lien or other Encumbrance on any material asset(s) or property of the Company or its subsidiaries except as noted on Schedule 3.10 or except as explicitly permitted or required under any other provision of this Agreement;

 

(f) entry into any contract or other agreement providing for payments by the Company or its subsidiaries in an aggregate amount exceeding $100,000 that is not terminable by the Company or its subsidiaries, as applicable, without penalty, upon sixty (60)-day notice, with the exception of agreements in the ordinary course of its business and consistent with past practice;

 

(g) any modification, termination or amendment to a material contract or waiver of any right or claim thereunder;

 

(h) any suspension or cancellation of any of the Company Permits or its subsidiaries Permits;

 

(i) loss of use of any the Company Intellectual Property; or

 

(j) any events that will result in any other Material Adverse Changes to The Company. For reference “Material Adverse Effect (or Change)” means, with respect to a particular Person, any event, fact, circumstances or condition that, individually or in the aggregate with any other such events, facts, circumstances or conditions, has had or would be reasonably expected to have (a) a material adverse effect on the business, results of operations, assets or financial condition of such Person and its subsidiaries (if any), taken as a whole, or (b) a material impairment of such Person’s ability to consummate the transactions contemplated hereby; provided, however, that the term “Material Adverse Effect or (Change)” shall not include any event, fact, circumstances or condition to the extent resulting from an action affirmatively taken by BUYING or its Affiliates after the date hereof and prior to the Closing Date; general economic changes or changes in the general industry of the Selling Party; acts of terrorism or war; or political or civil instability, disturbance or unrest.

 

Section 3.10 Real Property; Title to Assets.

 

(a) Section 3.11(a) of the Disclosure Schedules lists all real property in which the Company and its subsidiaries have an ownership or leasehold (or subleasehold) interest (together with all buildings, structures, and improvements located thereon, the “Real Property”), including: (i) the street address of each parcel of Real Property; (ii) for Real Property that is leased or subleased by the Company or its subsidiaries, the landlord under the lease, the rental amount currently being paid, and the expiration of the term of such lease or sublease, and any termination or renewal rights of any party to the lease; and (iii) the current use of each parcel of Real Property. Selling Parties have delivered or made available to Buying Parties true, correct, and complete copies of all Contracts, title insurance policies, and surveys relating to the Real Property.

 

8

 

 

(b) The Company and its subsidiaries have good and valid (and, in the case of owned Real Property, good and indefeasible fee simple) title to, or a valid leasehold interest in, all Real Property and personal property and other assets (other than properties and assets sold or otherwise disposed of in the ordinary course of business consistent with past practice). All Real Property and other assets (including leasehold interests) are free and clear of Encumbrances except for those items set forth in Section 3.11(b) of the Disclosure Schedules.

 

(c) Neither the Company nor its subsidiaries are a sublessor or grantor under any sublease or other instrument granting to any other Person any right to possess, lease, occupy, or use any leased Real Property. The use of the Real Property in the conduct of the Company’s and its subsidiaries’ business does not violate in any material respect any Law, covenant, condition, restriction, easement, license, permit, or Contract and no material improvements constituting a part of the Real Property encroach on real property owned or leased by a Person other than the Company or its subsidiaries.

 

Section 3.11 Intellectual Property.

 

(a) The term “Intellectual Property” means any and all of the following in any jurisdiction throughout the world: (i) issued patents and patent applications; (ii) trademarks, service marks, trade names, and other similar indicia of source or origin, together with the goodwill connected with the use of and symbolized by, and all registrations, applications for registration, and renewals of, any of the foregoing; (iii) copyrights, including all applications and registrations; (iv) trade secrets, know-how, inventions (whether or not patentable), technology, and other confidential and proprietary information and all rights therein; (v) internet domain names and social media accounts and pages; and (vi) other intellectual or industrial property and related proprietary rights, interests, and protections.

 

(b) Section 3.12(b) of the Disclosure Schedules lists all issued patents, registered trademarks, domain names and copyrights, and pending applications for any of the foregoing and all material unregistered Intellectual Property that are owned by the Company and its subsidiaries, including Wintus (the “Company IP Registrations”). The Company and its subsidiaries, each own or have the valid and enforceable right to use all Intellectual Property used or held for use in or necessary for the conduct of the their respective business as currently conducted or as proposed to be conducted (the “Company Intellectual Property”), free and clear of all Encumbrances. All of the Company Intellectual Property is valid and enforceable, and all Company IP Registrations are subsisting and in full force and effect. The Company and its subsidiaries have taken all necessary steps to maintain and enforce the Company Intellectual Property.

 

(c) The conduct of the Company’s and its subsidiaries’ business as currently and formerly conducted and as proposed to be conducted has not infringed, misappropriated, or otherwise violated and will not infringe, misappropriate, or otherwise violate the Intellectual Property or other rights of any Person. No Person has infringed, misappropriated, or otherwise violated any Company Intellectual Property.

 

9

 

 

Section 3.12 Legal Proceedings; Governmental Orders.

 

(a) Except as stated under Schedule 3.13, there are no claims, actions, causes of action, demands, lawsuits, arbitrations, inquiries, audits, notices of violation, proceedings, litigation, citations, summons, subpoenas, or investigations of any nature, whether at law or in equity (collectively, “Actions”) pending or, to the respective Selling Party’s knowledge, threatened against or by the Selling Party, or any Affiliate of the Selling Party, as applicable: (i) relating to or affecting the Company and its subsidiaries or any of the Company’s or its subsidiaries’ properties or assets; or (ii) that challenge or seek to prevent, enjoin, or otherwise delay the transactions contemplated by this Agreement. Except as set forth on Schedule 3.13, to the knowledge of the respective Selling Party, no such Action has been threatened. Except as set forth on Schedule 3.13, there is no judgment, decree, injunction, rule or order of any Governmental Body or arbitrator outstanding against the respective Selling Party.

 

(b) There are no outstanding, and the Company and its subsidiaries are in compliance with all, Governmental Orders against, relating to, or affecting the Company, its subsidiaries or any of their respective properties or assets.

 

Section 3.13 Compliance with Laws; Permits.

 

(a) The Company and its subsidiaries, each have complied, and are now complying, with all Laws applicable to them or their business, properties, or assets.

 

(b) All permits, licenses, franchises, approvals, registrations, certificates, variances, and similar rights obtained, or required to be obtained, from Governmental Authorities (collectively, “Permits”) in order for the Company and its subsidiaries to conduct their business, including, without limitation, owning or operating any of the Real Property, have been obtained and are valid and in full force and effect. Section 3.14(b) of the Disclosure Schedules lists all current Permits issued to the Company or its subsidiaries and no event has occurred that would reasonably be expected to result in the revocation or lapse of any such Permit.

 

(c) Taxes.

 

(i) All returns, declarations, reports, information returns and statements, and other documents relating to Taxes (including amended returns and claims for refund) (collectively, “Tax Returns”) required to be filed by the Company or its subsidiaries on or before the Closing Date have been timely filed. Such Tax Returns are true, correct, and complete in all respects. All Taxes due and owing by the Company or its subsidiaries (whether or not shown on any Tax Return) have been timely paid. No extensions or waivers of statutes of limitations have been given or requested with respect to any Taxes of the Company or its subsidiaries. Selling Parties have delivered to Buying Parties copies of all Tax Returns and examination reports of the Company or its subsidiaries and statements of deficiencies assessed against, or agreed to by, the Company or its subsidiaries, for all Tax periods ending after closing date. The term “Taxes” means all federal, state, local, foreign, and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration, profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental, stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs, duties, or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest, additions, or penalties with respect thereto.

 

10

 

 

(ii) Neither the Company nor its subsidiaries have been a member of an affiliated, combined, consolidated, or unitary Tax group for Tax purposes. Neither the Company nor its subsidiaries have any Liability for Taxes of any Person (other than the Company) under Treasury Regulations Section 1.1502-6 (or any corresponding provision of state, local, or foreign Law), as transferee or successor, by contract, or otherwise.

 

(iii) Reserved.

 

Section 3.14 Books and Records. The minute books and equity record and transfer books of the Company and its subsidiaries, all of which are in the possession of the Company or its subsidiaries and have been made available to Buying Parties, are complete and correct.

 

Section 3.15 Employee Benefits. Schedule 3.16 contains a complete and accurate list of all plans and material benefit obligations (the “Employee Benefit Plan”) sponsored, maintained or contributed to by the Company or any of its subsidiaries on behalf of or for the benefit of its current or former employees, directors or independent contractors. The Selling Parties has delivered or made available to Buying Parties a true and correct copy of the governing plan document for each Employee Benefit Plan (including all amendments thereto).

 

Section 3.16 Environmental Matters. Except for such matters as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect:

 

a) Compliance with Environmental Laws. The Company and its subsidiaries have, and have been, in compliance with all Environmental Laws, which compliance includes the possession, maintenance of, compliance with, or application for, all Permits required under applicable Environmental Laws for the operation of the business of the Company and its subsidiaries as currently conducted.

 

b) No disposal, release, or discharge of hazardous substances. The Company and its subsidiaries have not disposed of, released, or discharged any hazardous substances on, at, under, in, or from any Real Property currently or, to the knowledge of the Company and its subsidiaries, formerly owned, leased, or operated by it or at any other location that is: (i) currently subject to any investigation, remediation, or monitoring; or (ii) reasonably likely to result in liability to the Company or its subsidiaries, in either case of (i) or (ii) under any applicable Environmental Laws.

 

c) No production or exposure of hazardous substances. The Company and its subsidiaries have not: (i) produced, processed, manufactured, generated, transported, treated, handled, used, or stored any hazardous substances, except in compliance with Environmental Laws, at any Real Property; or (ii) exposed any employee or any third party to any hazardous substances under circumstances reasonably expected to give rise to any material Liability or obligation under any Environmental Law.

 

11

 

 

d) No Legal Actions or Orders. Except as disclosed in Schedule 3.17(d) neither the Company nor its subsidiaries have received any written notice of and there is no legal action pending, or to the knowledge of the Company and its subsidiaries, threatened against the Company or its subsidiaries, alleging any liability or responsibility under or non-compliance with any Environmental Law or seeking to impose any financial responsibility for any investigation, cleanup, removal, containment, or any other remediation or compliance under any Environmental Law. The Company and its subsidiaries are not subject to any order, settlement agreement, or other written agreement by or with any Governmental Authority or third party imposing any material liability or obligation with respect to any of the foregoing.

 

e) No Assumption of Environmental Law Liabilities. Except as disclosed in Schedule 3.17(e), neither the Company nor its subsidiaries have assumed or retained any liabilities under any applicable Environmental Laws of any other Person, including in any acquisition or divestiture of any property or business.

 

“Environmental Laws” means any applicable Law, and any order or binding agreement with any Governmental Authority: (a) relating to pollution (or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health or safety, or the environment (including ambient air, soil, surface water or groundwater, or subsurface strata); or (b) concerning the presence of, exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge, transportation, processing, production, disposal or remediation of any hazardous materials.

 

Section 3.17 Employees and Labor Relations.

 

a) Schedule 3.18 hereto correctly sets forth the name and current annual salary of the Company’s and its subsidiaries’ full-time employees receiving more than $120,000 in annual compensation and whether any employees are absent from active employment, including, but not limited to, leave of absence or disability.

 

b) Except as set forth on Schedule 3.18, the Company and its subsidiaries are not party to any collective bargaining agreement or relationship; to the Company’s and its subsidiaries’ knowledge, no key employee or group of employees of the Company and its subsidiaries have any plans to terminate employment therewith; and to the Company’s and its subsidiaries’ knowledge, there are not any material labor relations problems (including any union organization or decertification activities, threatened or actual strikes or work stoppages or material employee grievances).

 

12

 

 

Section 3.18 Relationships with Customers, Sales Agents, and Suppliers. Attached hereto as Schedule 3.19 is a true and accurate list of (i) the names of the Company’s and its subsidiaries top ten customers (not including individual customer) or sales agents (by dollar volume of sales to such customers or from the sales agents) and (ii) the names of the top ten suppliers of the Company and its subsidiaries (by dollar volume of purchases from such carriers), for the 2020, 2021 and 2022 fiscal years and, for each such customer (not including individual customer) or sales agent, as applicable, the volume of purchases by such customer or sold by the sales agent, as applicable, for each such fiscal year. Neither the Company or its subsidiaries have received any written notice from any material customer (not including individual customer) or key sales agent (except as listed on Schedule 3.19) to the effect that, and the Company or its subsidiaries, to their knowledge, have no reason to believe that, any material customer (not including individual customer) or key sales agent will stop, materially decrease the rate of, or materially change the terms (whether related to payment, volume, price or otherwise) with respect to, buying the silk products or services from the Company or its subsidiaries (whether as a result of the consummation of the transactions contemplated hereby or otherwise). Neither the Company or its subsidiaries have received any written notice from any of its material supplier (except as listed on Schedule 3.19) to the effect that, and the Company or its subsidiaries, to their knowledge, have no reason to believe that, such supplier will stop, materially decrease the rate of, or materially change the terms (whether related to payment, volume, price or otherwise) with respect to, supplying raw products or services to the Company or its subsidiaries (whether as a result of the consummation of the transactions contemplated hereby or otherwise).

 

Section 3.19 Full Disclosure. No representation or warranty by Selling Parties in this Agreement and no statement contained in the Disclosure Schedules to this Agreement or any certificate or other document furnished or to be furnished to Buying Parties pursuant to this Agreement contains any untrue statement of a material fact, or omits to state a material fact necessary to make the statements contained therein, in light of the circumstances in which they are made, not misleading.

 

ARTICLE IV

Representations and warranties of buying parties

 

Buying Parties represent and warrant to the Selling Parties that the statements contained in this Article IV are true and correct as of the date hereof, unless specified therein.

 

Section 4.01 Organization and Authority of Buyer. As of the Closing Date, each of the Buying Parties is a corporation duly organized, validly existing, and in good standing under the Laws of the jurisdictions of its incorporation. Each of the Buying Parties has full corporate power and authority to enter into this Agreement and the other Transaction Documents to which the respective Buying Party is a party, to carry out its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby. The execution and delivery by the respective Buying Party of this Agreement and any other Transaction Document to which the respective Buying Party is a party, the performance by the respective Buying Party of its obligations hereunder and thereunder, and the consummation by the respective Buying Party of the transactions contemplated hereby and thereby have been duly authorized by all requisite corporate action on the part of the respective Buying Party. This Agreement and each Transaction Document constitute legal, valid, and binding obligations of Buyer enforceable against the respective Buying Party in accordance with their respective terms.

 

13

 

 

Section 4.02 No Conflicts; Consents. The execution, delivery, and performance by the respective Buying Party of this Agreement and the other Transaction Documents to which it is a party, and the consummation of the transactions contemplated hereby and thereby, do not and will not: (a) violate or conflict with any provision of the certificate of incorporation, by-laws, or other governing documents of the respective Buying Party; (b) violate or conflict with any provision of any Law or Governmental Order applicable to the respective Buying Party; or (c) require the consent, notice, declaration, or filing with or other action by any Person or require any Permit, license, or Governmental Order.

 

Section 4.03 Investment Purpose. Buyer is acquiring the equity interest solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof or any other security related thereto within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).

 

ARTICLE V

General Covenants

 

Section 5.01 Confidentiality. From and after the Closing, Selling Parties shall, and shall cause their respective Affiliates and its and their respective directors, officers, employees, consultants, counsel, accountants, and other agents (collectively, “Representatives”) to, hold in confidence any and all information, in any form, concerning the Company, except to the extent that the Selling Party can show that such information: (a) is generally available to and known by the public through no fault of the Selling Party, any of its Affiliates, or their respective Representatives; or (b) is lawfully acquired by Sellers, any of its Affiliates, or their respective Representatives from and after the Closing from sources which are not prohibited from disclosing such information by any obligation. If a Selling Party or any of its Affiliates or their respective Representatives are compelled to disclose any information by Governmental Order or Law, such Selling Party shall promptly notify the other parties to the Agreement, in writing and shall disclose only that portion of such information which is legally required to be disclosed; provided, however, Selling Parties shall use reasonable best efforts to obtain as promptly as possible an appropriate protective order or other reasonable assurance that confidential treatment will be accorded such information.

 

Section 5.02 Further Assurances. Following the Closing, each of the parties hereto shall, and shall cause their respective Affiliates to, execute and deliver such additional documents and instruments and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement and the other Transaction Documents.

 

Section 5.03 Legend. Upon Closing, the all certificates or book entry evidencing the common Parent Shares being delivered by the Parent to the Sellers will bear the following legend, as well as any legend required under applicable state securities laws:

 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED”

 

14

 

 

Section 5.04 Right of First Refusal. The Company agrees that for a period of three (3) years following the Closing the Buying Parties shall have the right of first refusal to subscribe, purchase or the right to receive any additional Equity Interest of the Company. If the Buying Parties fail to accept in writing any such proposal for such transfer within ten (10) calendar days after receipt of a written notice from any of the Seller containing such proposal, then the Buying Parties shall have no claim or right with respect to any such transfer contained in any such notice. If, thereafter, such proposal is modified in any material respect, such Seller will adopt the same procedure as with respect to the original proposed transfer, and the Buying Parties shall have the right of first refusal with respect to such revised proposal in accordance with the terms of this Section 5.04.

 

Section 5.05 From the date of this Agreement to Closing, none of the Selling Parties shall encumber in any manner, such as imposing or creating any liens, mortgages, pledges or any other encumbrances, any of the assets owned by the respective Selling Party, except in the ordinary course of the Company’s and its subsidiaries’ business.

 

Section 5.06 Both the Selling Parties and the Buying Parties agree that the Selling Parties shall be jointly and severally liable for any liabilities, debts and obligations incurred by any the Company and its subsidiaries prior to the Closing, and the Buying Parties shall not be required to provide funding or services to pay off any liabilities and debts or fulfill any obligations incurred by the Company and its subsidiaries prior to the Closing.

 

Section 5.07 Access and Investigations. Between the date of this Agreement and the Closing Date, the Selling Parties and its representatives will, during normal business hours: (i) afford Buying Parties and their representatives reasonable access to the Selling Parties’ properties, contracts, books and records, and other documents and data, (ii) afford Buying Parties and its representatives reasonable access to the Selling Parties’ personnel, customers, suppliers and licensors, provided that the Buying Parties notify the Selling Parties in advance of the personnel, customers, suppliers and licensors to which they want access, and will allow the Selling Parties to participate in any contacts with such personnel, customers, suppliers and licensors, (iii) furnish or make available to Buying Parties and Buying Parties’ representatives copies of all such contracts, books and records, and other existing documents and data as Buying Parties may reasonably request, and (iv) furnish or make available to Buying Parties and Buying Parties’ representatives such additional financial, operating, and other data and information as Buying Parties may reasonably request so long as such request does not unreasonably interfere with the operation of the Selling Parties’ business in the ordinary course.

 

Section 5.08 Between the date of this Agreement and the Closing Date, the Selling Parties shall:

 

(a) except as set forth on Schedule 5.08(a), conduct the business of the Company only in the ordinary course of business consistent with past practice;

 

(b) not pay dividends or make any cash or stock distributions to the Sellers, except for payment of customary year-end bonuses in an amount consistent with prior years’ practices;

 

15

 

 

(c) not withdraw cash or liquidate marketable securities for the payment of amounts outside of the ordinary course of business, except as approved by the Buying Parties in writing;

 

(d) not amend any of the Company’s organization documents;

 

(e) not issue any ordinary shares or rights to acquire ordinary shares;

 

(f) use commercially reasonable efforts to maintain the goodwill of the Company’s and its subsidiaries’ suppliers, customers, distributors, licensors and employees; and

 

(g) not create, incur, assume or suffer to exist any Encumbrance not in existence on the date of this Agreement except as approved by the Buying Parties in writing.

 

Section 5.09 Except as otherwise expressly permitted by this Agreement or as set forth on Schedule 5.09, between the date of this Agreement and the Closing Date, the Selling Parties will not, without the prior consent of Buying Parties, take any affirmative action, or fail to take any reasonable action within its control, as a result of which any of the changes or events listed in Section 3.09 would reasonably be expected to occur.

 

Section 5.10 The Selling Parties shall cooperate with Parent and Parent’s Accountants in their timely preparation of audited consolidated financial statements of the Parent in compliance with the United States Generally Accepted Accounting Principles (the “U.S. GAAP”) for the periods required by Rule 3-05(b) of Regulation S-X promulgated by the United States Securities and Exchange Commission.

 

Section 5.11 Any of the Selling Parties shall give prompt written notice to Buying Parties of any development causing, or which would reasonably be expected to cause, a breach of any of the Selling Party’s representations and warranties set forth in Article III above. No disclosure by any Selling Party pursuant to this Section 5.11, however, shall be deemed to amend or supplement the Disclosure Schedules or to prevent or cure any misrepresentation or breach of warranty by such Selling Party.

 

Section 5.12 Assignment of Voting Rights. Each of the Seller shall execute an irrevocable power of attorney agreement, substantially in the form of Exhibit F herein, with respect to their respective rights to vote Parent Shares in all matters and things that the shareholders of the Parent have the right to vote upon.

 

16

 

 

ARTICLE VI

CONDITIONS PRECEDENT TO BUYING PARTIES’ OBLIGATION TO CLOSE

 

Buying Parties’ obligation to subscribe the Shares and to take the other actions required to be taken by the Buying Parties at the Closing is subject to the satisfaction, at or prior to the Closing, of each of the following conditions (any of which may be waived in writing by either of the Buying Parties, in whole or in part):

 

6.1 Accuracy of Representations. Each of the representations and warranties of the Selling Parties contained in this Agreement, including any updated schedules, shall be true and correct (but determined in each case without giving effect to any qualifications therein referencing the terms “material” or “Material Adverse Effect” or other terms of similar import or effect) when made and as of the Closing (with the same force and effect as if made as of the Closing), except where all failures of such representations and warranties to be so true and correct have not had, and would not reasonably be expected to have, in the aggregate, a Material Adverse Effect on the Selling Parties or the Buying Parties.

 

6.2 Covenants. Each of the covenants and other agreements contained in this Agreement to be complied with by the Selling Parties on or before the Closing Date shall have been complied with in all material respects.

 

6.3 Third Party Consents. Each of the consents shall have been obtained by the Selling Parties on terms and conditions reasonably acceptable to Buying Parties and shall be in full force and effect.

 

6.4 No Proceedings. Since the date of this Agreement, there must not have been commenced against the Buying Parties, or against any Person affiliated with the Buying Parties, any Actions that, in the reasonable good faith judgment of Buying Parties, based on the advice of outside counsel, would have a reasonable prospect of surviving a motion for summary judgment by the Buying Parties before any Governmental Authority of competent jurisdiction which (a) seeks to enjoin, restrain or otherwise prohibit the consummation of the transactions contemplated hereby; (b) seeks to impose criminal penalties in connection with the consummation of the transactions contemplated hereby; or (c) would reasonably be expected to have a Material Adverse Effect on the Selling Parties or Buying Parties, including, without limitation, preventing, delaying, making illegal, or otherwise interfering with the consummation of any of the transactions contemplated hereby.

 

6.5 Closing Deliveries. The Buying Parties shall have received each of the deliveries set forth herein.

 

6.6 Reserved.

 

6.7 Termination/Amendment of Stockholder Agreements. Each of the Sellers and shall have their respective shareholding agreement either terminated or amendment, as applicable.

 

6.8 Affiliate Leases. The Buying Parties shall have been granted access to all real property leases entered into by and between the Selling Parties (and/or its subsidiaries) and any officer, director, stockholder, employee or Affiliate of such Selling Parties (or an Affiliate of any of the foregoing), and the terms of each such lease shall have been satisfactory to Buying Parties in its sole and absolute discretion.

 

6.9 Satisfaction of Legal and Financial Due Diligence. Buying Parties and its counsel shall have completed their legal and financial due diligence concerning the Selling Parties, the results of which shall have been satisfactory to Buying Parties in its sole discretion.

 

6.10 Shareholder Approval. The closing of the transactions contemplated under this Agreement is subject to approval by a meeting of the shareholders of the Parent who hold a majority of the total issued and outstanding shares of common stock of the Parent.

 

17

 

 

ARTICLE VII

Tax matters

 

Section 7.01 Tax Covenants.

 

(a) Without the prior written consent of Buyer, the Selling Parties, to the extent it may affect or relate to the Company or its subsidiaries: (i) make, change, or rescind any Tax election; (ii) amend any Tax Return; (iii) take any position on any Tax Return; or (iv) take any action, omit to take any action, or enter into any other transaction that would have the effect of increasing the Tax liability or reducing any Tax asset of Buyer or the Company and its subsidiaries, in respect of any taxable period that begins after the Closing Date or, in respect of any taxable period that begins before and ends after the Closing Date (each such period, a “Straddle Period”), the portion of any Straddle Period beginning after the Closing Date.

 

(b) All transfer, documentary, sales, use, stamp, registration, value added, and other such Taxes and fees (including any penalties and interest) incurred in connection with this Agreement and the other Transaction Documents shall be borne and paid by Selling Parties when due. Selling Parties shall, at their own expense, timely file any Tax Return or other document with respect to such Taxes or fees (and Buyer shall cooperate with respect thereto as necessary).

 

(c) Buyer shall prepare, or cause to be prepared, all Tax Returns required to be filed by the Company and its subsidiaries after the Closing Date with respect to any taxable period or portion thereof ending on or before the Closing Date and all Straddle Period Tax Returns. Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law) and without a change of any election or any accounting method.

 

Section 7.02 Straddle Period. In the case of Taxes that are payable with respect to a Straddle Period, the portion of any such Taxes that are allocated to Pre-Closing Tax Periods (as defined in Section 7.03) for purposes of this Agreement shall be: (a) in the case of Taxes: (i) based upon, or related to, income, receipts, profits, wages, capital, or net worth; (ii) imposed in connection with the sale, transfer, or assignment of property; or (iii) required to be withheld, the amount of Taxes which would be payable if the taxable year ended with the Closing Date; and (b) in the case of other Taxes, the amount of such Taxes for the entire period multiplied by a fraction, the numerator of which is the number of days in the period ending on the Closing Date and the denominator of which is the number of days in the entire period.

 

18

 

 

Section 7.03 Tax Indemnification. Selling Parties shall indemnify the Buying Parties and each Buyer Indemnitee (as defined in Section 8.01) and hold them harmless from and against (a) any loss, damage, liability, deficiency, Action, judgment, interest, award, penalty, fine, cost or expense of whatever kind (collectively, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification under this Agreement, “Losses”) attributable to any breach of or inaccuracy in any representation or warranty made in Section 3.14(c); (b) any Loss attributable to any breach or violation of, or failure to fully perform, any covenant, agreement, undertaking, or obligation in ARTICLE VIII; (c) all Taxes of the Company and its subsidiaries or relating to the business of the Company and its subsidiaries for all Pre-Closing Tax Periods (as defined below); (d) all Taxes of any member of an affiliated, consolidated, combined, or unitary group of which the Company and its subsidiaries (or any predecessor of the Company) are or were a member on or prior to the Closing Date by reason of a liability under Treasury Regulation Section 1.1502-6 or any comparable provisions of foreign, state, or local Law; and (e) any and all Taxes of any Person imposed on the Company and its subsidiaries arising under the principles of transferee or successor liability or by contract, relating to an event or transaction occurring before the Closing Date. In each of the above cases, together with any out-of-pocket fees and expenses (including attorneys’ and accountants’ fees) incurred in connection therewith, Selling Parties shall reimburse Buyer for any Taxes of the Company and its subsidiaries that are the responsibility of Selling Parties pursuant to this Section 7.03 within ten (10) Business Days after payment of such Taxes by Buyer or the Company. The term “Pre-Closing Tax Period” means any taxable period ending on or before the Closing Date and, with respect to any taxable period beginning before and ending after the Closing Date, the portion of such taxable period ending on and including the Closing Date.

 

Section 7.04 Cooperation and Exchange of Information. Selling Parties and Buying Parties shall provide each other with such cooperation and information as either of them reasonably may request of the other in filing any Tax Return pursuant to this ARTICLE VIII or in connection with any proceeding in respect of Taxes of the Company and its subsidiaries, including providing copies of relevant Tax Returns and accompanying documents. Each of Selling Parties and Buying Parties shall retain all Tax Returns and other documents in its possession relating to Tax matters of the Company and its subsidiaries for any Pre-Closing Tax Period (collectively, “Tax Records”) until the expiration of the statute of limitations of the taxable periods to which such Tax Records relate.

 

ARTICLE VIII

Indemnification

 

Section 8.01 Indemnification by Sellers. Subject to the other terms and conditions of this ARTICLE VIII, Selling Parties shall indemnify and defend each of Buying Parties and its Affiliates (including the Company) and their respective Representatives (collectively, the “Buyer Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Buyer Indemnitees based upon, arising out of, with respect to, or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of Sellers contained in this Agreement or the other Transaction Documents; or

 

(b) any breach or non-fulfillment of any covenant, agreement, or obligation to be performed by Sellers pursuant to this Agreement or the other Transaction Documents.

 

Section 8.02 Indemnification by Buyer. Subject to the other terms and conditions of this ARTICLE VIIII, Buyer shall indemnify and defend each of Sellers and its Affiliates and their respective Representatives (collectively, the “Seller Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Seller Indemnitees based upon, arising out of, with respect to, or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of Buyer contained in this Agreement or the other Transaction Documents; or

 

(b) any breach or non-fulfillment of any covenant, agreement, or obligation to be performed by Buyer pursuant to this Agreement.

 

19

 

 

Section 8.03 Indemnification Procedures. Whenever any claim shall arise for indemnification hereunder, the party entitled to indemnification (the “Indemnified Party”) shall promptly provide written notice of such claim to the other party (the “Indemnifying Party”). In connection with any claim giving rise to indemnity hereunder resulting from or arising out of any Action by a Person who is not a party to this Agreement, the Indemnifying Party, at its sole cost and expense and upon written notice to the Indemnified Party, may assume the defense of any such Action with counsel reasonably satisfactory to the Indemnified Party. The Indemnified Party shall be entitled to participate in the defense of any such Action, with its counsel and at its own cost and expense. If the Indemnifying Party does not assume the defense of any such Action, the Indemnified Party may, but shall not be obligated to, defend against such Action in such manner as it may deem appropriate, including settling such Action, after giving notice of it to the Indemnifying Party, on such terms as the Indemnified Party may deem appropriate and no action taken by the Indemnified Party in accordance with such defense and settlement shall relieve the Indemnifying Party of its indemnification obligations herein provided with respect to any damages resulting therefrom. The Indemnifying Party shall not settle any Action without the Indemnified Party’s prior written consent (which consent shall not be unreasonably withheld or delayed).

 

Section 8.04 Survival. Subject to the limitations and other provisions of this Agreement, the representations and warranties contained herein and all related rights to indemnification shall survive the Closing and shall remain in full force and effect until the date that is five (5) years from the Closing Date; provided, however, the representations and warranties in Section 3 and Section 4.02 shall survive indefinitely. Subject to ARTICLE VIII, all covenants and agreements of the parties contained herein shall survive the Closing indefinitely unless another period is explicitly specified herein. Notwithstanding the foregoing, any claims which are timely asserted in writing by notice from the non-breaching party to the breaching party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation or warranty and such claims shall survive until finally resolved.

 

Section 8.05 Tax Claims. Notwithstanding any other provision of this Agreement, the control of any claim, assertion, event, or proceeding in respect of Taxes of the Company and its subsidiaries (including, but not limited to, any such claim in respect of a breach of the representations and warranties in Section 3.14(c) hereof or any breach or violation of or failure to fully perform any covenant, agreement, undertaking, or obligation in ARTICLE VII) shall be governed exclusively by Article VII hereof.

 

20

 

 

Section 8.06 Cumulative Remedies. The rights and remedies provided for in this ARTICLE VIII (and in Article VII) are cumulative and are in addition to and not in substitution for any other rights and remedies available at Law or in equity or otherwise.

 

ARTICLE IX

TERMINATION

 

9.1 Termination Events. This Agreement may, by notice given prior to or at the Closing, be terminated:

 

(a) by either Selling Parties or Buying Parties if a material breach of any provision of this Agreement has been committed by a Selling Party (in the case of a termination by Buying Parties) or a Buying Party (in the case of a termination by the Selling Parties) and such breach has not been waived, provided that written notice has been given to such other parties of the intention to terminate under this Section 9.l(a) due to such breach and such other parties have not cured such breach within fifteen (15) Business Days of receipt of such notice;

 

(b) by mutual written consent of all of the parties; or

 

(c) by any party if the Closing has not occurred (other than through the failure of any party seeking to terminate this Agreement to comply with its obligations under this Agreement) on or before December 31, 2023, or such later date that the parties may agree upon in writing.

 

9.2 Effect of Termination. Each Party’s right of termination under Section 9.1 is in addition to any other rights it may have under this Agreement or otherwise, and the exercise of a right of termination will not be an election of remedies. If this Agreement is terminated pursuant to Section 9.1, all further obligations of the parties under this Agreement will terminate, except that the provisions of Article VIII will survive after such termination; provided that if this Agreement is terminated by a party because of the breach of the Agreement by the other party or because one or more of the conditions to the terminating party’s obligations under this Agreement is not satisfied as a result of the other party’s failure to comply with its obligations under this Agreement, the terminating party’s right to pursue all legal remedies will survive such termination unimpaired for a period of six (6) months after such termination.

 

ARTICLE X

Miscellaneous

 

Section 10.01 Expenses. All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

 

21

 

 

Section 10.02 Notices. All notices, claims, demands, and other communications hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by email of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient; or (d) on the [third] day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid, if sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 10.02):

 

If to Selling Parties:

House 81, Seasons Villas, Kam Tin, NT, Hong Kong

Email: 1300188392@qq.com

Attention: Yan Chi Keung, CEO

   
with a copy (which shall not constitute notice) to:

Beijing Dentons Law Firm

16-21/F, Block B, Zhaotai International Center, No. 10

Chaoyangmen South Street, Chaoyang District, Beijing

Email: shuhong.you@dentons.cn

Attention: Shuhong You

   
If to Buying Parties:

Room 1603, New World Center Apartment,

Dongcheng District, Beijing 100062

Email: secretary@shineco.tech

Attention: CEO

   
with a copy (which shall not constitute notice) to:

Sichenzia Ross Ference LLP

1185 Avenue of the Americas

31st Floor, New York, NY 10036

Email: hlou@SRF.LAW

Attention: Huan Lou

 

Section 10.03 Interpretation; Headings. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

Section 10.04 Severability. If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Agreement.

 

22

 

 

Section 10.05 Entire Agreement. This Agreement and the other Transaction Documents constitute the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein and therein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this Agreement and those in the other Transaction Documents, any exhibits, and the Disclosure Schedules (other than an exception expressly set forth as such in the Disclosure Schedules), the statements in the body of this Agreement will control.

 

Section 10.06 Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither party may assign its rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed. No assignment shall relieve the assigning party of any of its obligations hereunder.

 

Section 10.07 Amendment and Modification; Waiver. This Agreement may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No failure to exercise, or delay in exercising, any right or remedy arising from this Agreement shall operate or be construed as a waiver thereof. No single or partial exercise of any right or remedy hereunder shall preclude any other or further exercise thereof or the exercise of any other right or remedy.

 

Section 10.08 Governing Law; Submission to Jurisdiction.

 

(a) All matters arising out of or relating to this Agreement shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction). Any legal suit, action, proceeding, or dispute arising out of or related to this Agreement, the other Transaction Documents, or the transactions contemplated hereby or thereby may be instituted in the federal courts of the United States of America, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, proceeding, or dispute.

 

Section 10.09 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

Section 10.10 Waiver. The rights and remedies of the parties to this Agreement are cumulative and not alternative. Neither the failure nor any delay by any party in exercising any right, power, or privilege under this Agreement or the documents referred to in this Agreement will operate as a waiver of such right, power, or privilege, and no single or partial exercise of any such right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege. To the maximum extent permitted by applicable law: (a) no claim or right arising out of this Agreement or the documents referred to in this Agreement can be discharged by one party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing signed by the other party; (b) no waiver that may be given by a party will be applicable except in the specific instance for which it is given; and (c) no notice to or demand on one party will be deemed to be a waiver of any obligation of such party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement or the documents referred to in this Agreement.

 

Section 10.11 This Agreement supersedes all prior agreements between the parties with respect to its subject matter and constitutes (along with the documents referred to in this Agreement) a complete and exclusive statement of the terms of the agreement between the parties with respect to its subject matter. This Agreement may not be amended except by a written agreement executed by all of the parties herein.

 

Section 10.12 If and to the extent any information required to be furnished in any Disclosure Schedule is contained in another Disclosure Schedule, such information will be deemed to be included in all Disclosure Schedules in which such information is required to be included, to the extent the relevance of such disclosure to such other Disclosure Schedules is reasonably apparent on its face.

 

[signature page follows]

 

23

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their duly authorized officers/representatives.

 

  Seller
     
  By                    
  Wang Xiaohui
  Individual
  Seller
     
  By  
     
  Yan Chi Keung
  Individual
     
  Shineco Life Science Group Hong Kong Co., Limited
     
  By  
  Jennifer Zhan
  CEO

 

  Dream Partner Limited
     
  By  
  Name: Yan Chi Keung
  Title: CEO

 

  Shineco, Inc.
     
  By                
  Jennifer Zhan
  CEO

 

  Chongqing Wintus Group
     
  By  
  Name: Yan Chi Keung
  Title: Chief Executive Officer

 

24

 EX-101.SCH 3 sisi-20230919.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sisi-20230919_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 sisi-20230919_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 19, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 19, 2023
Entity File Number 001-37776
Entity Registrant Name SHINECO, INC.
Entity Central Index Key 0001300734
Entity Tax Identification Number 52-2175898
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One T1, South Tower, Jiazhaoye Square
Entity Address, Address Line Two Chaoyang District,
Entity Address, City or Town Beijing
Entity Address, Country CN
Entity Address, Postal Zip Code 100062
City Area Code +86
Local Phone Number 10-67084339
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol SISI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001300734 2023-09-19 2023-09-19 iso4217:USD shares iso4217:USD shares 0001300734 false 8-K 2023-09-19 SHINECO, INC. DE 001-37776 52-2175898 T1, South Tower, Jiazhaoye Square Chaoyang District, Beijing CN 100062 +86 10-67084339 false false false false Common Stock SISI NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( -J;-%<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #:FS17;$8^CNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R(G'H";UI66G#08K;.QF;+4UC6-C:R1]^R59FS*V!]C1TN]/ MGT"-B=*$A"\I1$SD,-\-ONVR-''-CD11 F1S1*]S.2:ZL;D/R6L:G^D 49N3 M/B#4G#^ 1])6DX8)6,2%R%1CC30)-85TP5NSX.-G:F>8-8 M>NPH0U56P-0T M,9Z'MH$;8((1)I^_"V@7XES]$SMW@%V20W9+JN_[LA=S;MRA@O?GI]=YW<)U MF71G7]ZF-R_>%W$_;!NKW[ MQ\970=7 K[M07U!+ P04 " #:FS17F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M -J;-%>E""S;600 X1 8 >&PO=V]R:W-H965T&UL MC9AO<^(V$,;?WZ?0N#.==DJ"9?XF!68((3UZ=X3&M#?33E\(6X :6_+)<@C] M]%T98M,[LR8O@F6\CW]:K9^5&>R4?DZWG!OR&D!*;K;$GFJ-!PC;;KH3.FMW=> MQP;D5_PA^"X].29V*BNEGNU@%@X=UQ+QB ?&2C#X>.$3'D56"3B^'$6=XIXV M\/3X3?TAGSQ,9L52/E'19Q&:[=#I.R3D:Y9%YDGMWO/CA'+ 0$5I_I_L#M>V MVPX)LM2H^!@,!+&0AT_V>DS$24#K7(!W#/!R[L.-'A_:L/"$2[@&BC*F,@"'.*AXAM MJBCP^#6+4HYP= J.SF7)6' M5$BF,B10?)5YP96*,JJKHVZ!UD4%I]((LRD5/+U+>)[X1MC*AIS-65R9*%S'?S^;3R>/ MC7>S^>0:X>H77/U+N":PBII%9"9#_DH^\'T5&:[D0KI:KMMKM1&LFP+KYA*L M)7LELQ#8Q%H$+'?O\XN)*W:\*X_V.OV;/H)'W=(MW4L 9S)0.E$Z9VL0WT#U M$Z7)1&604,BK"BL7N4;]?HI!GE@ZO01R'(9@A&GC[8!\A.O(HZPFPR67%&8) M37U+EFK'=8/\*MB_6Z;VG/A?,J8Q6Z%E$Z"HA^/@RYVJ!,J$:'N5;?G]MNMU@T&578)BIO[9RV,X1)R$\>9 M/'IQ6@F&"]5M/6C9(2ANZ+Z*1" ,/"WD$[BN%BRJY,%5ZGB\LB-XN&JMTJAHE6Y]*OB/PYQL5/&-XI<=[N"DO-0MMF?G[ M>*4JBZQ&P)_Y,XRDM'0/-^*WS)#I:["%9L;/[B)KA.9C_W[\&\94NKIWD:M/ M8ZXW-DN_@ )L#V E$B:KUQ 7/%M7S9.W6_M+P2=F[YB2B*]!R+WN@:X^O'P? M!D8E^0OO2AEX??H!OPL0( .(, - >&PO9 MKEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R M6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8 MRY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>% ME#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY M85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$ M&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ* M3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"? M@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S M/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM M%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&89 M4IT,/O'^8* \^>Q\ETWLJ.?]74_P$ M4$L#!!0 ( -J;-%>7BKL

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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biosisi.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm sisi-20230919.xsd sisi-20230919_lab.xml sisi-20230919_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "sisi", "nsuri": "http://biosisi.com/20230919", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "sisi-20230919.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "sisi-20230919_lab.xml" ] }, "presentationLink": { "local": [ "sisi-20230919_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://biosisi.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://biosisi.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001493152-23-033251-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-033251-xbrl.zip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